SCHEMBL8935846

SCHEMBL8935846

CC(C)(OCc1ccc(C(F)(F)F)cc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 8/20 0.50
▸ PPARD Q03181 7/20 0.50
▸ MAOB P27338 3/20 0.50
▸ PPARG P37231 3/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ IDO1 P14902 2/20 0.49
▸ SRD5A2 P31213 1/20 0.44
▸ FFAR1 O14842 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ MMP1 P03956 1/20 0.43
▸ MMP12 P39900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8935661 0.83 SLC16A3 (0.46) PPARAMAOBPPARGKMT2AIDO1
SCHEMBL883026 0.80 SLC16A3 (0.55) PPARAPPARDPPARGKMT2A
SCHEMBL13042083 0.80 SRD5A2 (0.43) PPARAPPARDMAOBPPARGSRD5A2
SCHEMBL2215266 0.79 RXRA (0.46) PPARAPPARDMAOBPPARGKMT2A
SCHEMBL2352150 0.79 RXRA (0.46) PPARAPPARDPPARGIDO1
SCHEMBL21991794 0.79 PPARA (0.77) PPARAPPARDMAOBPPARGFFAR1
SCHEMBL19220762 0.78 IDO1 (0.59) MAOBKMT2AIDO1
SCHEMBL13205914 0.78 HDAC1 (0.41) PPARAPPARDMAOBPPARGSRD5A2
SCHEMBL31377393 0.78 NPC1 (0.53) PPARAPPARDPPARGIDO1FFAR1
SCHEMBL2221138 0.78 SLC16A3 (0.53) PPARGIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1070487-C Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO CO (JP) 2001-09-05 — — CN disclosed
US-5491167-A INHIBITORS OF CHOLESTEROL BIOSYNTHESIS SANKYO COMPANY, LIMITED (JP) 1996-02-13 — — US disclosed
EP-0609058-A2 Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1994-08-03 — — EP disclosed
Send feedback